Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Direxion Daily FTSE China Bull 3x Shares (YINN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Direxion Daily FTSE China Bull 3x Shares — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.51 (market cap $2.27B), while Direxion Daily FTSE China Bull 3x Shares trades at $25.07 (market cap $560.32M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 4.1× Direxion Daily FTSE China Bull 3x Shares's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Direxion Daily FTSE China Bull 3x Shares nearer its low. Which is the better fit depends on your goals.
| SLS | YINN | |
|---|---|---|
Market Cap | $2.27B | $560.32M |
Volume | 4,179,659 | 1,009,521 |
Sector | Health | Leveraged / Inverse |
52-Week High | $15.46 | $52.69 |
52-Week Low | $1.39 | $21.45 |
Enterprise Value | $2.14B | — |
Typical Hold Time | — | 25 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
YINN is trading at $23.56, down 2.97% with bearish technical indicators showing 18 sell signals versus 1 buy. The stock faces resistance at $24 with support at $23. Recent corporate actions include a $0.56 dividend scheduled for September 2026. Technical analysis indicates strong bearish momentum with moving averages unanimously negative.
The outlook remains challenging with bearish technical positioning and limited fundamental data availability. Key risks include market volatility and sector-specific headwinds. Investment opportunities may emerge if the stock stabilizes above support levels, but current momentum suggests continued downward pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Direxion Daily FTSE China Bull 3x Shares
YINN is a leveraged ETF that seeks daily investment results, before fees and expenses, of 300% (3x) of the daily performance of the FTSE China 50 Index. It is a tactical instrument designed for sophisticated traders seeking to magnify short-term bullish views on large-cap Chinese equities, primarily those trading on the Hong Kong Stock Exchange.
Read more on YINN →
